Sign In
Get Clay Free →

Suggestions

    Mark Mullikin

    Chief Financial Officer at Vedanta Biosciences, Inc.

    Mark Mullikin is the Chief Financial Officer (CFO) of Vedanta Biosciences, Inc., a clinical-stage biotechnology company focused on developing therapies derived from the human microbiome. He was appointed to this position on February 8, 2021, and brings over 25 years of experience in finance within the life sciences sector.12

    Professional Background

    Prior Roles::

    • Editas Medicine: Before joining Vedanta, Mullikin served as Vice President of Finance and Investor Relations at Editas Medicine, where he played a significant role in raising approximately $700 million in equity capital.12
    • Novartis: He held various leadership roles at Novartis, focusing on financial and strategic planning as well as health economics and pricing strategies.13
    • Healthcare Equity Analyst: Mullikin also has experience as a healthcare equity analyst at Adage Capital Management and Piper Sandler. His career began in the finance and strategy practice at Deloitte Consulting.12

    Education::

    • M.B.A. in Finance: He earned his Master of Business Administration from the MIT Sloan School of Management.
    • B.A. in Economics: Mullikin holds a Bachelor of Arts degree in Economics from the University of Chicago.12

    Contributions to Vedanta Biosciences

    At Vedanta, Mullikin is expected to leverage his extensive background in biotech finance to guide the company's financial strategy as it develops innovative therapies for conditions such as C. difficile infection, inflammatory bowel diseases, and food allergies. His expertise is seen as crucial for navigating the complexities of funding and managing clinical trials in a rapidly evolving field.13

    Mullikin has expressed enthusiasm about joining Vedanta at a pivotal moment for the company, highlighting its leadership position in the microbiome therapeutics space.12

    For further professional details, Mullikin maintains a LinkedIn profile under the username markmullikin, where he connects with over 500 professionals in his network.4

    Highlights

    Feb 8 · vedantabio.com
    Vedanta Biosciences Appoints Mark Mullikin as Chief Financial Officer
    PureTech Founded Entity Vedanta Biosciences Appoints Mark Mullikin ...

    Related Questions

    What are Mark Mullikin's key achievements at Editas Medicine?
    How did Mark Mullikin's role at Novartis prepare him for his position at Vedanta Biosciences?
    What are the main challenges Mark Mullikin faces as CFO at Vedanta Biosciences?
    How does Vedanta Biosciences' approach to microbiome therapies differ from other companies?
    What are the upcoming clinical trial readouts for Vedanta Biosciences?
    Mark Mullikin
    Mark Mullikin, photo 1
    Mark Mullikin, photo 2
    Add to my network

    Location

    Greater Boston